CSIMarket
 


Acelrx Pharmaceuticals Inc  (ACRX)
Other Ticker:  
 

Acelrx Pharmaceuticals Inc's Quick Ratio

ACRX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




ACRX Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change -10.62 % -1.13 % 29.56 % 44.87 % 98.31 %
Y / Y Cash & cash equivalent Change 26.64 % 27.73 % -35.16 % -46.49 % -52.28 %
Quick Ratio MRQ 3.77 4.33 2.43 2.6 2.66
Overall Ranking # # # # #
Seq. Current Liabilities Change -5.53 % -11.86 % 6.49 % 0.79 % 4.51 %
Seq. Cash & cash equivalent Change -17.85 % 57.03 % -0.32 % -1.52 % -17.14 %



Quick Ratio second quarter 2021 Comment
Despite sequential decrease in Current Liabilities, Quick Ratio detoriated to 3.77 below company average Quick Ratio.

Within Major Pharmaceutical Preparations industry 254 other companies have achieved higher Quick Ratio than Acelrx Pharmaceuticals Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ACRX Segments?
See Quick Ratio ACRX on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 255
Healthcare Sector # 524
Overall Market # 1240


Quick Ratio Statistics
High Average Low
20.16 5.93 1.91
(Mar 31 2014)   (Sep 30 2012)




Financial Statements
Acelrx Pharmaceuticals Inc's Current Liabilities $ 15 Millions Visit ACRX's Balance sheet
Acelrx Pharmaceuticals Inc's Cash & cash equivalent $ 55 Millions Visit ACRX's Balance sheet
Source of ACRX's Sales Visit ACRX's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Metacrine Inc   9.99 $ 74.813  Millions$ 7.492  Millions
Ngm Biopharmaceuticals Inc   9.74 $ 390.550  Millions$ 40.080  Millions
Catalyst Pharmaceuticals Inc   9.62 $ 155.275  Millions$ 16.135  Millions
Sierra Oncology Inc   9.59 $ 90.690  Millions$ 9.461  Millions
Imara inc   9.58 $ 66.768  Millions$ 6.973  Millions
Ocular Therapeutix Inc   9.56 $ 191.860  Millions$ 20.063  Millions
9 Meters Biopharma Inc   9.55 $ 64.098  Millions$ 6.715  Millions
Insmed Inc  9.32 $ 928.327  Millions$ 99.656  Millions
Contrafect Corp  9.24 $ 67.499  Millions$ 7.309  Millions
Landos Biopharma Inc   9.19 $ 115.127  Millions$ 12.530  Millions
Larimar Therapeutics Inc   9.18 $ 70.630  Millions$ 7.691  Millions
United Therapeutics Corporation  9.17 $ 1,967.500  Millions$ 214.600  Millions
F star Therapeutics Inc   9.03 $ 81.648  Millions$ 9.041  Millions
Ocuphire Pharma Inc   8.98 $ 24.234  Millions$ 2.699  Millions
Kadmon holdings inc   8.92 $ 270.494  Millions$ 30.318  Millions
Verastem Inc   8.91 $ 108.135  Millions$ 12.134  Millions
Edesa Biotech Inc   8.91 $ 8.053  Millions$ 0.904  Millions
Arbutus Biopharma Corp  8.87 $ 78.379  Millions$ 8.841  Millions
Recro Pharma Inc   8.62 $ 45.724  Millions$ 5.303  Millions
Foghorn Therapeutics Inc   8.61 $ 141.273  Millions$ 16.414  Millions
Zynerba Pharmaceuticals Inc   8.55 $ 85.781  Millions$ 10.028  Millions
Bicycle Therapeutics Plc  8.54 $ 198.738  Millions$ 23.273  Millions
Inspire Medical Systems inc   8.54 $ 207.836  Millions$ 24.350  Millions
Fulcrum Therapeutics inc   8.44 $ 125.550  Millions$ 14.867  Millions
Eton Pharmaceuticals Inc   8.31 $ 25.802  Millions$ 3.106  Millions
Chinook Therapeutics Inc   8.29 $ 197.150  Millions$ 23.770  Millions
Nurix Therapeutics Inc   8.24 $ 386.021  Millions$ 46.844  Millions
Corcept Therapeutics Inc  8.15 $ 369.982  Millions$ 45.402  Millions
Innoviva inc   8.06 $ 43.265  Millions$ 5.371  Millions
Neurobo Pharmaceuticals Inc   8.04 $ 9.513  Millions$ 1.183  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ABMC's Profile

Stock Price

ABMC's Financials

Business Description

Fundamentals

Charts & Quotes

ABMC's News

Suppliers

ABMC's Competitors

Customers & Markets

Economic Indicators

ABMC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071